the United States and other countries, utilize FLOW cytometry and spot images obtained with a microscopic camera that are analyzed by recognition software to distinguish the particles seen. Technicians often review these images as well to check their validity and then a measurement of RBCs (and other entities in the urine) is formulated. These are reported as RBCs/HPF based on correlations made with traditional microscopy on a limited number of samples when the machines are calibrated.
These machines can process 50-200 samples per hour, far more than the 30 or so an hour that can be reviewed by traditional microscopy, explaining their growing popularity in the past 5 years. The authors go on to describe the validation standards which differ for each machine as well as their correlations to the traditional microscopic urinalysis. Moreover, the quantification is usually put into groups (e.g. 0-4 RBC/HPF, 5-10 RBC/HPF, etc.), further clouding the correlation with traditional microscopy.
My colleagues at the University of Rochester and I were unaware that these machines existed, let alone that they were in such widespread use, and had no idea which machine(s) were at our hospitals. Indeed, we found out that at the three major hospitals in our healthcare system, three different machines are used. Also, we do not know which machines are used by other hospitals, from where we often are sent patients, and what their calibration standards are.
The concern, of course, is that without knowing those standards and how they correlate with microscopic urinalysis, we may not even be asked to see patients with microhematuria by the traditional definition. While bladder cancer is almost never found incidentally at autopsy and so will eventually be diagnosed, [5] this may occur at more advanced stages, leading to greater morbidity and possibly mortality for bladder cancer patients [3] .
The take-home message for all of us is to at least know which machines are in use at the institutions where we work and their related laboratories, and try to influence the lab directors to calibrate their machines to a low number of RBCs (0-2 or 3) as the "normal group". Urologists are already somewhat derelict in performing cystoscopy in patients with microhematuria and increased risk factors for harboring urologic malignancies [6] , and one would not want to increase this problem by relying on a relaxed or uncertain definition of microhematuria.
